Viewing Study NCT02505269

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-02-21 @ 8:40 AM
Study NCT ID: NCT02505269
Status: COMPLETED
Last Update Posted: 2020-08-24
First Post: 2015-07-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma
Sponsor: Massachusetts General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None limited stage View
None Hodgkin's disease View
None non-bulky View